文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

miR-139-5p通过靶向MNT调控急性早幼粒细胞白血病细胞的增殖。

miR-139-5p Regulates the Proliferation of Acute Promyelocytic Leukemia Cells by Targeting MNT.

作者信息

Fu Yueyue, Li Limin, Hou Jinxiao, Li Huibo, Lv Chengfang, Yu Hongjuan, Zhang Xiaoqian, Xu Mengyuan, Zhang Mingwen, Meng Hongbin, Liu Jie, Lian Xin, Feng Jiawei, Zhou Jin

机构信息

Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, Heilongjiang, China.

Department of Hematology, South University of Science and Technology Hospital, Shenzhen, China.

出版信息

J Oncol. 2021 Apr 16;2021:5522051. doi: 10.1155/2021/5522051. eCollection 2021.


DOI:10.1155/2021/5522051
PMID:33953744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064781/
Abstract

Acute promyelocytic leukemia (APL) patients with progressive leukocytosis are more likely to have various complications and poor outcomes. However, the regulatory roles of microRNAs in the leukocytosis of APL have not been clarified. Our study aims to evaluate the effects of miRNAs on leukocytosis during induction therapy of APL patients and explore its potential mechanisms. During induction treatment, patients with white blood cell count higher than 10 × 10/L were divided into leukocytosis group and others were nonleukocytosis group. Using microarray assays, we found that miR-139-5p was significantly downregulated in the leukocytosis group. Elevated expression of miR-139-5p inhibited the proliferation of NB4 cells by arresting the cell cycle and inducing apoptosis. We further identified that MNT was a target of miR-139-5p. miR-139-5p significantly inhibited the proliferation, invasion, and migration function of NB4 cells through targeting MNT. Strategies for regulating miR-139-5p or MNT expression might provide new therapeutic approaches for progressive leukocytosis in APL.

摘要

急性早幼粒细胞白血病(APL)患者若出现进行性白细胞增多,则更易出现各种并发症且预后较差。然而,微小RNA在APL白细胞增多中的调控作用尚未阐明。我们的研究旨在评估微小RNA对APL患者诱导治疗期间白细胞增多的影响,并探究其潜在机制。在诱导治疗期间,白细胞计数高于10×10⁹/L的患者被分为白细胞增多组,其他患者为非白细胞增多组。通过微阵列分析,我们发现白细胞增多组中miR-139-5p显著下调。miR-139-5p表达升高通过使细胞周期停滞并诱导凋亡来抑制NB4细胞的增殖。我们进一步确定MNT是miR-139-5p的一个靶标。miR-139-5p通过靶向MNT显著抑制NB4细胞的增殖、侵袭和迁移功能。调节miR-139-5p或MNT表达的策略可能为APL进行性白细胞增多提供新的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/8b1e7807e701/JO2021-5522051.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/8b607126c874/JO2021-5522051.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/0bd8528628d1/JO2021-5522051.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/388993ee1fa3/JO2021-5522051.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/8b1e7807e701/JO2021-5522051.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/8b607126c874/JO2021-5522051.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/0bd8528628d1/JO2021-5522051.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/388993ee1fa3/JO2021-5522051.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6924/8064781/8b1e7807e701/JO2021-5522051.004.jpg

相似文献

[1]
miR-139-5p Regulates the Proliferation of Acute Promyelocytic Leukemia Cells by Targeting MNT.

J Oncol. 2021-4-16

[2]
miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.

Cell Signal. 2018-11-17

[3]
miR-299-5p promotes cell growth and regulates G1/S transition by targeting p21Cip1/Waf1 in acute promyelocytic leukemia.

Oncol Lett. 2016-7

[4]
Apoptosis induction in acute promyelocytic leukemia cells through upregulation of by miR-182 blockage.

Mol Biol Res Commun. 2018-3

[5]
MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.

Eur Rev Med Pharmacol Sci. 2019-8

[6]
[microRNAs expression profile in acute promyelocytic leukemia cell differentiation induced by all-trans retinoic acid and arsenic trioxide].

Zhonghua Xue Ye Xue Za Zhi. 2012-7

[7]
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.

Cell Oncol (Dordr). 2016-8-1

[8]
miR-218 inhibits acute promyelocytic leukemia cell growth by targeting BMI-1.

Oncol Lett. 2017-12

[9]
MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.

Biomed Pharmacother. 2020-1-28

[10]
miR-96-5p Regulates Proliferation, Migration, and Apoptosis of Vascular Smooth Muscle Cell Induced by Angiotensin II via Targeting NFAT5.

J Vasc Res. 2020

引用本文的文献

[1]
The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases.

Pharmaceutics. 2022-9-14

[2]
Clinical Value of Serum miRNA in Patients with Acute Promyelocytic Leukemia.

J Oncol. 2022-4-1

[3]
, an Emerging Gate-Keeper in Various Types of Cancer.

Cells. 2022-2-22

本文引用的文献

[1]
Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia.

Sci Rep. 2019-8-15

[2]
miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.

Cell Signal. 2018-11-17

[3]
Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial.

Blood. 2018-9-27

[4]
Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide.

Ann Hematol. 2017-12

[5]
Long-term outcome of acute promyelocytic leukemia treated with all--retinoic acid, arsenic trioxide, and gemtuzumab.

Blood. 2017-3-9

[6]
MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.

Blood. 2016-9-7

[7]
Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.

Cancer Sci. 2016-9

[8]
miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.

Pathol Res Pract. 2016-7

[9]
Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation.

Oncotarget. 2016-2-16

[10]
MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.

Biochem Biophys Res Commun. 2015-10-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索